Safety and tolerability of cyclosporin A (Sandimmun®) in idiopathic nephrotic syndrome

Clinical Nephrology

Volumn 35, Issue SUPPL. 1, 1991, Pages

  Von Graffenried, B ^a   Feutren, G ^a   Schiess, W ^a   Rohrmann, C ^a   Brodehl, J ^a   Meyrier, A ^a   Niaudet, P ^a   Ponticelli, C ^a  

^a Sandoz Pharma Ltd   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ADULT; BIOPSY; CHILD; CONFERENCE PAPER; FEMALE; GLOMERULOSCLEROSIS; HODGKIN DISEASE; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; CHILD; CREATININE; CYCLOSPORINS; DRUG TOLERANCE; FEMALE; GLOMERULOSCLEROSIS, FOCAL; HUMAN; KIDNEY; KIDNEY FUNCTION TESTS; MALE; NEPHROSIS, LIPOID; TIME FACTORS;

EID: 0025894090     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)